Heart monitoring while on BTK inhibitor therapy
Part of Blood & lymphatic, Cancer, Heart & circulation, Injuries & trauma clinical trials.
This study uses a small device placed under the skin to continuously monitor your heart rhythm while you take a BTK inhibitor (a type of targeted therapy for blood cancer). The goal is to catch irregular heartbeats early, which can be a side effect of these medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have a blood cancer that requires treatment with ibrutinib, acalabrutinib, or zanubrutinib.
- Your doctor expects you to stay on this treatment for at least 12 months.
- You have a regular heart rhythm at the start of the study (no atrial fibrillation).
- You are willing to sign a consent form and attend study visits.
- You do not have a pacemaker, implantable defibrillator, or certain heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a connected watch can help monitor an irregular heart rhythm (atrial fibrillation) after heart surgery. It looks at people who develop new atrial fibrillation after surgery and compares how well monitoring works over the next 12 months.
This study checks how often abnormal heart rhythms happen when you start a BTK inhibitor (used for certain blood cancers). It uses a small implanted heart monitor to record your rhythm continuously before and after starting the medication, so doctors can detect and manage problems early.
This study watches for high blood pressure and irregular heartbeats in people with CLL who are starting a type of targeted therapy called a BTK inhibitor (acalabrutinib or zanubrutinib). Researchers will use a smartwatch and blood pressure cuff to monitor your heart health at home.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This registry study follows people who get a BIOTRONIK implantable heart monitor and use home monitoring. It looks at how routine care and at-home check-ins work in real life, which may help improve support and tracking over time.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.